COVID-19 and Hartnup disease: an affair of intestinal amino acid malabsorption.

COVID-19 and Hartnup disease: an affair of intestinal amino acid malabsorption.
Eat Weight Disord. 2020 Jul 20;:
Authors: Nisoli E, Cinti S, Valerio A
Abstract
Since the outbreak of COVID-19, clinicians have tried every effort to fight the disease, and multiple drugs have been proposed. However, no proven effective therapies currently exist, and different clinical phenotypes complicate the situation. In clinical practice, many severe or critically ill COVID-19 patients developed gastrointestinal (GI) disturbances, including vomiting, diarrhoea, or abdominal pain, even in the absence of cough and dyspnea. Understanding the mechanism of GI disturbances is warranted for exploring better clinical care for COVID-19 patients. With evidence collected from clinical studies on COVID-19 and basic research on a rare genetic disease (i.e., Hartnup disorder), we put forward a novel hypothesis to elaborate an effective nutritional therapy. We hypothesize that SARS-CoV-2 spike protein, binding to intestinal angiotensin-converting enzyme 2, negatively regulates the absorption of neutral amino acids, and this could explain not only the GI, but also systemic disturbances in COVID-19. Amino acid supplements could be recommended.Level of evidence No level of evidence: Hypothesis article.
PMID: 32691334 [PubMed - as supplied by publisher]

Source: Eating and weight disorders : EWD - July 19, 2020 Category: Eating Disorders & Weight Management Authors: Nisoli E, Cinti S, Valerio A Tags: Eat Weight Disord Source Type: research